After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Zevra Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Zevra Therapeutics Inc is $460.95M. A total of 0.73 million shares were traded on the day, compared to an average of 494.42K shares.
In the most recent transaction, Watton Corey Michael bought 300 shares of ZVRA for 7.84 per share on Mar 28 ’25. After the transaction, the Director now owns 1,800 company shares. In a previous transaction on Mar 19 ’25, Bode John B bought 10,000 shares at 7.96 per share. ZVRA shares that Director owns now total 40,000.
Among the insiders who sold shares, Sangiovanni Timothy J. disposed of 3,000 shares on Feb 13 ’25 at a per-share price of $7.86. This resulted in the SVP, Finance & Corp Controller holding 16,341 shares of ZVRA after the transaction. In another insider transaction, Schafer Joshua sold 10,500 shares at $7.86 per share on Feb 13 ’25. Company shares held by the CCO & EVP, Bus. Development now total 29,486.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ZVRA has a high of $9.76 and a low of $4.20.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ZVRA’s latest balance sheet shows that the firm has $112.35M in Cash & Short Term Investments as of fiscal 2021. There were $1.61M in debt and $4.23M in liabilities at the time. Its Book Value Per Share was $0.75, while its Total Shareholder’s Equity was $127.12M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZVRA is Buy with a score of 5.00.
